Inactive

EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES

Inactive

DESCRIPTION The purpose of the solicitation will be to recompete a NIAID resource entitled “EVALUATION AND TESTING SERVICES (ETSV) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES” that provid... DESCRIPTION The purpose of the solicitation will be to recompete a NIAID resource entitled “EVALUATION AND TESTING SERVICES (ETSV) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES” that provides a suite of preclinical, non-clinical, and clinical testing services for vaccines and other biologic products. While the overall suite of testing services is comprehensive, the intent is to provide individual services on a case-by-case basis for a diverse collection of vaccine and biological product candidates, rather than carry a single product candidate through an entire preclinical development pathway. These services are intended to help a wide variety of investigators in a broad number of scientific areas obtain critical data needed to acquire additional funding, gain prospective partnerships (either for further development or to support Phase I/II/III clinical trials), fulfill regulatory requirements, and complete studies needed to apply for an IND and enter Phase I/II/III clinical trials. These testing capabilities may also support vaccines or other biological products that are intended to interrupt or block pathogen transmission (such as vector-borne diseases) or for use in animals that constitute a disease reservoir for, or other disease threat from, a pathogen that has public health significance. Support for efforts associated with zoonotic diseases may be considered on a case-by-case basis dependent on adequate justification for public health considerations.